Page last updated: 2024-08-16

tyramine and probenecid

tyramine has been researched along with probenecid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Bunney, W; Gillin, JC; Jimerson, D; Karoum, F; Van Kammen, D; Wyatt, RJ1
Bläsig, J; Gramsch, C; Herz, A1
Quebbemann, AJ; Rennick, BR1
Deiman-Van Aalst, WM; Eigeman, L; Vaatstra, WJ1
Egelund, J; Gliemann, L; Hellsten, Y; Isakson, BE; Jørgensen, TS; Kiehn, OT; Maagaard, C; Nielsen, MS; Nyberg, M; Piil, P1

Reviews

1 review(s) available for tyramine and probenecid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for tyramine and probenecid

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Effect of probenecid on the concentration of the lumbar cerebrospinal fluid acidic metabolites of tyramine, octopamine, dopamine and norepinephrine.
    Biochemical pharmacology, 1977, Apr-01, Volume: 26, Issue:7

    Topics: Dopamine; Female; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Male; Norepinephrine; Octopamine; Probenecid; Schizophrenia; Tyramine

1977
Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
    European journal of pharmacology, 1977, Aug-01, Volume: 44, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzomorphans; Catechol O-Methyltransferase; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Male; Monoamine Oxidase; Morphine; Naloxone; Probenecid; Rats; Substance Withdrawal Syndrome; Time Factors; Tyramine

1977
Effects of structural modifications of catecholamines on renal tubular transport in the chicken.
    The Journal of pharmacology and experimental therapeutics, 1969, Volume: 166, Issue:1

    Topics: Aminohippuric Acids; Animals; Biological Transport; Carbon Isotopes; Catecholamines; Chickens; Dopamine; Epinephrine; Ethylamines; Isoproterenol; Kidney Tubules; Norepinephrine; Octopamine; Phenethylamines; Probenecid; Quinine; Tetraethylammonium Compounds; Tritium; Tyramine

1969
Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    European journal of pharmacology, 1981, Mar-12, Volume: 70, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Blood Platelets; In Vitro Techniques; Male; Mice; p-Chloroamphetamine; Probenecid; Quinolines; Quipazine; Rabbits; Rats; Serotonin; Serotonin Antagonists; Synaptosomes; Tyramine

1981
Probenecid Inhibits α-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature.
    Hypertension (Dallas, Tex. : 1979), 2018, Volume: 71, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Arteries; Blood Pressure; Connexins; Extremities; Humans; Male; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Probenecid; Receptors, Adrenergic; Regional Blood Flow; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents

2018